MCM
ASMB icon

Moore Capital Management’s Assembly Biosciences ASMB Stock Holding History

Moore Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-833
Closed -$197K – 322
2019
Q1 		$197K Hold
833
– – 0.01% 270
2018
Q4 		$226K Hold
833
– – 0.01% 212
2018
Q3 		$371K Buy
+833
New +$390K 0.01% 259

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Moore Capital Management's ASMB Position: Q2 2019 in Review

Moore Capital Management sold out of Assembly Biosciences (ASMB) in Q2 2019, closing a stake of 833 shares — an estimated $197K sold.

Moore Capital Management first reported a position in ASMB in Q3 2018 and held it in 3 quarters. The position peaked at $371K in Q3 2018. 106 funds tracked by Wall St. Rank hold ASMB as of Q2 2019.

  • Moore Capital Management reported no remaining Assembly Biosciences position as of Q2 2019 after selling out during the quarter.
  • Moore Capital Management sold 833 Assembly Biosciences shares in Q2 2019, an estimated $197K.
  • Moore Capital Management first reported a position in Assembly Biosciences in Q3 2018 and held it in 3 quarters.
  • Moore Capital Management's Assembly Biosciences position peaked at $371K in Q3 2018.
  • 106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2019.

Based on Moore Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.